Recurrent or Progressive Diffuse Intrinsic Pontine Glioma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent or Progressive Diffuse Intrinsic Pontine Glioma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT05278208

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS)…

United States65 participantsStarted 2022-11-21

Treatment: LUTATHERA® (Lutetium Lu 177 dotatate)

All recent trials (9 shown)

Active — Not RecruitingPhase 1

NCT02359565

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrin…

This phase I trial studies the side effects and best dose of pembrolizumab and to see how well it works in treating younger patients with high-grade gliomas (br…

United States71 participantsStarted 2015-06-03

Treatment: Biospecimen Collection, Conventional Magnetic Resonance Imaging

Active — Not RecruitingNot Applicable

NCT03033992

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

This is a multicenter trial of the Optune device to examine the feasibility and to describe the device-related toxicity in children with supratentorial high gra…

United States80 participantsStarted 2017-04-04

Treatment:

Recurrent or Progressive Diffuse Intrinsic Pontine Glioma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

All recent trials (9 shown)

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrin…

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

All recent trials (9 shown)

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrin…

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and At…

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Re-Irradiation of Progressive or Recurrent DIPG

A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)

PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma